STOCK TITAN

Modular Med Inc - MODD STOCK NEWS

Welcome to our dedicated page for Modular Med news (Ticker: MODD), a resource for investors and traders seeking the latest updates and insights on Modular Med stock.

Modular Medical Inc (NASDAQ: MODD) delivers innovative insulin pump technology designed to transform diabetes care. This news hub provides investors and healthcare professionals with essential updates on the company's progress in medical device development, regulatory milestones, and strategic partnerships.

Access timely information about MODD's patented diabetes management solutions, including FDA clearances, manufacturing expansions, and clinical advancements. Our curated news collection helps stakeholders track developments in user-friendly insulin delivery systems and the company's mission to expand access to affordable diabetes technology.

Key updates include product innovation timelines, regulatory submissions, intellectual property developments, and partnership announcements. Bookmark this page for consolidated access to MODD's latest achievements in medical device engineering and diabetes care solutions.

Rhea-AI Summary
Modular Medical, Inc. provides an update on its ongoing pre-submission testing and timeline for submission of its MODD-1 insulin pump to the FDA. The company has made substantial progress on completing many of the required tests and has received results from some of the longest lead time tests, including insulin stability and potency. Modular Medical expects to make its FDA submission around year end 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.59%
Tags
none
-
Rhea-AI Summary
Modular Medical announces collaboration with Phillips-Medisize for insulin pump technology
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.84%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.77%
Tags
none
-
Rhea-AI Summary
Modular Medical, Inc. has announced the pricing of an underwritten public offering of its common stock and warrants. The units are being sold at a combined price of $2.13 per unit, with each unit comprising two shares of common stock and one warrant to purchase one share of common stock. The net proceeds from the offering are expected to be approximately $8.3 million. The offering is expected to close on May 18, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32%
Tags
Rhea-AI Summary

Modular Medical, Inc. (NASDAQ:MODD) has updated its progress on the MODD-1 insulin pump, transitioning to a full commercial version designed with a tier-1 medical product manufacturer. This new version aims to resolve prior material compatibility issues, enhance cost-effectiveness, and streamline usability. The company anticipates submitting the device for FDA approval in the quarter ending December 31, 2023, following the arrival of key production equipment and subsequent testing. The initiative seeks to make insulin delivery technology more accessible and user-friendly for diabetes patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.79%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) has updated on the development of its insulin pump product, MODD1. The company is making progress on the testing needed for its 510(k) submission to the FDA. However, they encountered compatibility issues with certain materials used in the device, delaying the submission timeline. Replacement materials have been identified and are in the qualification process. Modular Medical now anticipates submitting to the FDA by June 30, 2023, pending resolution of these issues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.13%
Tags
none
-
Rhea-AI Summary

Modular Medical, Inc. (NASDAQ:MODD) announced plans for Chief Executive Officer Jeb Besser to present at upcoming investor conferences. Besser will speak at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 10:50 a.m. ET, and will also conduct one-on-one meetings. The following day, he will host one-on-one meetings at the Benchmark Company's 11th Annual Discovery Investor Conference. Modular Medical aims to revolutionize insulin delivery technology, making it simpler and more affordable for diabetes patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.69%
Tags
conferences
News
Rhea-AI Summary

Modular Medical Inc. (NASDAQ:MODD) has updated investors on its insulin pump product, the MODD1. The company is nearing completion of its 510(k) submission to the FDA but has encountered a materials compatibility issue that has delayed the submission timeline, now expected between December 2022 and June 2023. Meanwhile, progress in establishing production capabilities is ahead of schedule and cost estimates are favorable. The CEO will attend investor conferences in late November 2022, with further updates on product development anticipated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.17%
Tags
none
Modular Med Inc

Nasdaq:MODD

MODD Rankings

MODD Stock Data

47.67M
37.04M
8.26%
43.67%
0.64%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO